GENTAGEOF 5%
Registered medicine brand reference
GEOFMAN PHARMACEUTICALS
DML: GENTAGEOF 5%
Available Forms
1Inj
1 pack100ml
Strength not recorded
Rs. 150
TP: Rs. 212.5
Active Ingredient
Other Brands of Gentamicin
38These brands list the same active ingredient as GENTAGEOF 5%, but they are not verified substitutes — strengths, dosage forms and pack sizes may differ, and availability varies by pharmacy. Compare with a pharmacist or prescriber before switching.
38 active related brands listed alphabetically.
AMINOGENT
VALOR PHARMACEUTICALS
BETACLINE-G
Caliph Pharmaceuticals (Pvt) Ltd. DML: 000748
B-GENTA
WELLBORNE PHARMACHEM AND BIOLOGICALS
GENEK
INNVOTEK PHARMACEUTICALS
GENOM
GEOFMAN PHARMACEUTICALS
GENTACIL
ATCO LABORATORIES LIMITED
GENTACIL
STAR LABORATORIES (PVT) LTD.
GENTACILINJECTION
ATCO LABORATORIES LIMITED
GENTAMICIN
ALBRO PHARMA
GENTAMICIN
KRKA-PAK PHARMACEUTICAL & CHEMICAL WORKS
GENTAMICIN
MEDIPAK LIMITED
GENTAMYCIN
VENUS PHARMA
GENTAMYCIN
AMROS PHARMACEUTICALS.
GENTAMYCIN
MEHRAN TRADERS
GENTAMYCIN
KRKA-PAK PHARMACEUTICAL & CHEMICAL WORKS
GENTAMYCIN
LAWRENCE PHARMA
GENTAMYCIN
ORIENT LABORATORIES
GENTASEPT
Hudson Pharma (Pvt) Ltd DML: 000842
GENTIC
BOSCH PHARMACEUTICALS (PVT) LTD.
GENTICYN
IRZA PHARMA (PVT) LTD.
GENTICYN PAED
IRZA PHARMA (PVT) LTD.
GENXAT
SURGE LABORATORIES (PVT) LTD.
GENZY
AKSON PHARMACEUTICALS (PVT) LTD.
GERMI
CAYLEX PHARMACEUTICALS (PVT) LTD.
GLYCOCIN
Maxitech Pharma (Pvt) Ltd. DML: 000851
G-MYCIN
MASS PHARMA (PRIVATE) LIMITED
G-OPTIN
FESTEL LAB
H-NEUGENTA
NEUTRO PHARMA (PVT) LTD.
I-GENT
IRZA PHARMA (PVT) LTD.
INFECTOFLAM
NOVARTIS PHARMA (PAK) LTD
MEDIGENTACIN
MEDIPAK LIMITED
OPHTH-FLUOGEN
OPHTH-PHARMA (PVT) LTD.
OPTAGEN
REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD.
OTOGEN
REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD.
PRIMAGENT
PRIME LABS. (PVT) LTD.
REFOBACIN
MARTIN DOW PHARMACEUTICALS (PAK) LTD.
TAMYCIN
S.J. & G. FAZUL ELLAHIE (PVT) LTD.
V-GENTA
VEGA PHARMACEUTICALS LTD.
For educational purposes only. Check current guidelines and consult a qualified healthcare professional before making clinical decisions.